Pelthos Therapeutics Inc. - PTHS
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$27.87M
QoQ value delta ($000)
+$14.92M
(+115.21%)
Implied price effect (QoQ)
+10.74%
Shares
Total shares
899,359
QoQ shares delta
+436,597
(+94.35%)
Total shares held by funds (by quarter)
Market chart (PTHS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Murchinson Ltd. | 8,973 | 289,479 | 1.44% |
| Ikarian Capital, LLC | 7,928 | 255,758 | 0.62% |
| BOOTHBAY FUND MANAGEMENT, LLC | 2,501 | 80,680 | 0.04% |
| J. Goldman & Co LP | 2,418 | 78,006 | 0.06% |
| VANGUARD GROUP INC | 2,325 | 75,020 | 0.0% |
| CANTOR FITZGERALD, L. P. | 1,084 | 34,990 | 0.02% |
| DIADEMA PARTNERS LP | 775 | 25,000 | 0.13% |
| Knott David M Jr | 597 | 19,281 | 0.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 422 | 13,625 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 342 | 11,057 | 0.0% |
| Pale Fire Capital SE | 251 | 8,100 | 0.02% |
| Persistent Asset Partners Ltd | 186 | 6,007 | 0.08% |
| Steward Partners Investment Advisory, LLC | 59 | 1,910 | 0.0% |
| UBS Group AG | 13 | 434 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 12 | 0.0% |